David Saito-Chung covers a history lesson with the 1994 market when the Fed doubled the target rate in a year's time. Dave discusses the parallels and differences that might act as a guide for the current market as well as individual stocks. Plus, when should your conviction in a stock give way to reality? Stocks on his watchlist include Alkermes (ALKS) and AstraZeneca (AZN) in the medical sector and bellwether Apple (AAPL) with earnings on tap. For the video version, visit investors.com/podcast.

Learn more about your ad choices. Visit megaphone.fm/adchoices